FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3759511000001101: Palfium 10mg tablets (Roche Products Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17709101000001113 Palfium 10mg tablets (Roche Products Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17709201000001118 Palfium 10mg tablets (Roche Products Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Palfium 10mg tablets (Roche Products Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) Is a Product containing precisely dextromoramide 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) Has active ingredient Dextromoramide tartrate false Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) Has active ingredient Dextromoramide false Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) Is a Palfium true Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dextromoramide true Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) Has specific active ingredient Dextromoramide tartrate true Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) Has basis of strength substance Dextromoramide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Palfium 10mg tablets (Roche Products Ltd) 60 tablet 2 x 30 tablets Is pack of False Palfium 10mg tablets (Roche Products Ltd) Inferred relationship Existential restriction modifier
Palfium 10mg tablets (Roche Products Ltd) 60 tablet 2 x 30 tablets Has AMP True Palfium 10mg tablets (Roche Products Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start